Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

By Mori Kiyoshi   Kamiyama Yukari   Kondo Tetsuro   Kano Yasuhiko   Kodama Tetsuro  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite

Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

By Mayerhofer K.   Kucera E.   Zeisler H.   Speiser P.   Reinthaller A.   Sevelda P.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite

Paclitaxel and Carboplatin Combination Chemotherapy in a Hemodialysis Patient with Advanced Ovarian Cancer

By Watanabe M.   Aoki Y.   Tomita M.   Sato T.   Takaki Y.   Kato N.   Kikuchi M.   Kase H.   Tanaka K.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 335-338

Elsevier

Access to resources Recommend Favorite

The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater

By Kim Seung  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1149-1154

Humana Press, Inc

Access to resources Recommend Favorite

"MECCA": A Developmental, Dose-Intensive, Non-Cross-Resistant Platinum-Based Chemotherapy for Advanced Ovarian Cancer

By Hoskins P.J.   Swenerton K.D.   Pike J.A.   Mcmurtrie E.M.   Lee N.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 345-351

Academic Press

Access to resources Recommend Favorite